Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 551 - 600 out of 8,102

Document Document Title
WO/2006/120813A1
An object of the invention is to provide a method capable of producing D-glucuronic acid and D-glucuronolactone easily and safely in high yield and at low cost. The invention provides a method for producing glucuronic acid and/or glucuro...  
WO2006094800A3
The invention relates to a process, which comprises converting a chemical substrate into a chemical product by a cascade reaction wherein an enzyme-catalysed chemical transformation reaction and a metal-catalysed chemical transformation ...  
WO2006084749A3
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C), e.g. the RCS 02 gene coding for an ?xidoreductase (EC 1.10) ....  
WO2006084643A3
The present invention relates to newly identified microorganisms capable of direct production of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also relates to polynucleotide sequences comprising genes that en...  
WO/2006/116487A3
Methods and compositions that can be used to make monatin from glucose, tryptophan, indole-3-lactic acid, indole-3-pyruvate, and 2-hydroxy 2-(indol-3-ylmethyl)-4-keto glutaric acid, are provided. Methods are also disclosed for producing ...  
WO/2006/116487A2
Methods and compositions that can be used to make monatin from glucose, tryptophan, indole-3-lactic acid, indole-3-pyruvate, and 2-hydroxy 2-(indol-3-ylmethyl)-4-keto glutaric acid, are provided. Methods are also disclosed for producing ...  
WO/2006/113147A3
Herein is disclosed a method of generating ascorbic acid from yeast transformed with a mannose epimerase. In a further embodiment, the yeast can be further transformed with a myoinositol phosphatase. In the method, the transformed yeast ...  
WO2005106011A3
A process for production of cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV is provided which employs a BOC-protected amine of the structure (3) prepared by subjecting an acid of the structure (1) to reduce amin...  
WO/2006/113147A2
Herein is disclosed a method of generating ascorbic acid from yeast transformed with a mannose epimerase. In a further embodiment, the yeast can be further transformed with a myoinositol phosphatase. In the method, the transformed yeast ...  
WO/2006/109198A3
The invention provides yeast strains, and polypeptides encoded by genes of such yeast strains, that have enantiospecific glycidyl ether hydrolase activity. The invention also features nucleic acid molecules encoding such polypeptides, ve...  
WO/2006/109198A2
The invention provides yeast strains, and polypeptides encoded by genes of such yeast strains, that have enantiospecific glycidyl ether hydrolase activity. The invention also features nucleic acid molecules encoding such polypeptides, ve...  
WO/2006/105843A3
The invention relates to a method for splitting rutinosides in order to obtain rhamnose and/or the corresponding aglycones. Said method is characterised in that the reaction is carried out in the presence of yeast. The invention also rel...  
WO/2006/101073A1
[PROBLEMS] To search a substance capable of inhibiting the induction of the expression of GRP78 to find a novel anti-cancer agent. [MEANS FOR SOLVING PROBLEMS] A novel compound represented by the chemical formula 1 is now found as a subs...  
WO2006084722A3
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO2006084720A3
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO2006084646A3
The present invention relates to newly identified microorganisms capable of direct production of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also relates to polynucleotide sequences comprising genes that en...  
WO2006084709A3
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also refeixed to as Vitamin C), The invention also features polynucleotides comprising the fu...  
WO/2006/099699A1
The invention discloses the demethylation of 5-methoxyflavonoids by bacterial enzymes, the use of these enzymes in the production of phytoestrogens in vitro, and in pharmaceutical compositions in combination with a source of methylated 5...  
WO2005074481A3
Methods for processing spectra are disclosed. The method includes obtaining a plurality of spectra (26), each spectrum in the plurality of spectra comprising a signal including a signal strength as a function of time-of-flight, mass-to-c...  
WO/2006/098959A1
The present invention is concerned with novel processes for the preparation of (R)-4,4-dimethoxy–pyran-3-ol. This compound is useful as an intermediate in the synthesis of compounds which possess pharmacological activity including CCR2...  
WO/2006/098585A1
The present invention relates to a method that improves productivity of a useful secondary metabolite by eliminating biological by-products effectively during the culture of a useful secondary metabolite-producing microorganism, and more...  
WO/2006/094945A3
The invention concerns a method for producing optically active alcohols of formula (I) by means of enzymatic reduction of the corresponding ketones, in particular, the production of (1S)-3-methylamino-1-(2-thienyl)-propane-1-ol and (1S)-...  
WO/2006/095444A1
A stemphone is produced by culturing cells of Aspergillus sp. FKI-2136 (NITE ABP-83), a microorganism belonging to the genus Aspergillus and capable of producing a stemphone, in a culture medium to accumulate the stemphone in the culture...  
WO/2006/094945A2
The invention concerns a method for producing optically active alcohols of formula (I) by means of enzymatic reduction of the corresponding ketones, in particular, the production of (1S)-3-methylamino-1-(2-thienyl)-propane-1-ol and (1S)-...  
WO/2006/094800A2
The invention relates to a process, which comprises converting a chemical substrate into a chemical product by a cascade reaction wherein an enzyme-catalysed chemical transformation reaction and a metal-catalysed chemical transformation ...  
WO/2006/093368A1
Disclosed is a kaempferol preparing method comprising isolating kaempferol from kaempferol glucosides using an acid, a base, an enzyme or a microbe producing the enzyme. More specifically, the method comprises obtaining a plant extract c...  
WO2006055528A3
The present disclosure provides enzymatic methods for generating stereoisomerically pure products by resolving a racemic mixture of N-protected ß-lactams with a lipase from Candida antarcticawith high stereospecificity. The presence of ...  
WO/2006/091669A1
Disclosed herein are various novel oxazolidinone, imidazolidinone, and thiazolidinone analogs and methods of treating cancer and/or microbial infection using these analogs. Particular 4-oxazolidinone compounds are shown to have anti-canc...  
WO/2006/084724A1
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO/2006/084642A3
The present invention relates to newly identified microorganisms capable of direct production of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also relates to polynucleotide sequences comprising genes that en...  
WO/2006/085535A1
Biopterin is a useful compound to be used in a pharmaceutical product or a functional food. Conventionally, the presence of sepiapterin reductase (SPR) involved in the biosynthesis of biopterin has not been confirmed in microorganisms wi...  
WO/2006/084749A2
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C), e.g. the RCS 02 gene coding for an &ogr xidoreductase (EC 1.1...  
WO/2006/084716A1
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO/2006/084726A1
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO/2006/084720A2
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO/2006/084736A1
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO/2006/084717A1
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO/2006/084646A2
The present invention relates to newly identified microorganisms capable of direct production of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also relates to polynucleotide sequences comprising genes that en...  
WO/2006/084729A1
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO/2006/084644A2
The present invention relates to newly identified microorganisms capable of direct production of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also relates to polynucleotide sequences comprising genes that en...  
WO/2006/084734A1
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO/2006/084730A1
The present invention relates to newly identified genes that encode proteins with oxidoreductase activity (e.g. EC 1.10) that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C) . The invention al...  
WO/2006/084723A1
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO/2006/084708A1
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO/2006/084706A2
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO/2006/084718A1
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO/2006/084709A2
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also refeixed to as Vitamin C), The invention also features polynucleotides comprising the fu...  
WO/2006/084733A1
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO/2006/084737A1
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO/2006/084725A1
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C) . The cloned gene encodes an ATP binding subunit of the sorbit...  

Matches 551 - 600 out of 8,102